Announcement
12 Feb 2021
In February 2021, the European Investment Bank (EIB) and OSE Immunotherapeutics signed a EUR 25 million (approx. USD 30.3 million) loan to support the company’s RDI activities.
Source
Sign in to access
Number of interventions
2
2 certainly harmful
0 likely harmful
0 liberalising
List of interventions
Implementation date
12 Feb 2021
Revocation date:
No revocation date
Updated: 12 Feb 2021
State loan
In force
The EIB's loan for the amount of EUR 25 million (approx. USD 30.3 million) loan with OSE Immunotherapeutics, signed on 12 February 2021, formed part of the EIB’s strategy to support biotech c...
Sign in to see more
Updated: 12 Feb 2021
State loan
In force
On 12 February 2021, the European Investment Bank (EIB) and OSE Immunotherapeutics signed a EUR 25 million (approx. USD 30.3 million) loan to support the company’s RDI investment in the devel...
Sign in to see more
Threads
See all
This state act is not part of any Thread yet.